Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/04/2017 → 31/12/2021 |
Funding
- IGEM Therapeutics Ltd: £314,429.00
Preclinical efficacy of an antibody of the IgE class against a melanoma-associated antigen
- Karagiannis, Sophia (Primary Investigator)
- Spicer, James (Primary Investigator)
Project: Research